Is cognitive decline a risk to your retirement?
New research reveals undiagnosed cognitive decline can cost retirees tens of thousands of dollars through bad investments or ...
The Lancet49m
Amyloid-lowering treatment in Alzheimer's disease
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...